BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 7562964)

  • 1. The epidemiology of Huntington's disease in Northern Ireland.
    Morrison PJ; Johnston WP; Nevin NC
    J Med Genet; 1995 Jul; 32(7):524-30. PubMed ID: 7562964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and mutation rates of Huntington's disease in Spain: experience of 9 years of direct genetic testing.
    Ramos-Arroyo MA; Moreno S; Valiente A
    J Neurol Neurosurg Psychiatry; 2005 Mar; 76(3):337-42. PubMed ID: 15716522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significant linkage disequilibrium between the Huntington's disease locus and markers at loci D4S10, D4S95, and D4S111 in Northern Ireland.
    Morrison PJ; Graham CA; Nevin NC
    J Med Genet; 1993 Dec; 30(12):1018-9. PubMed ID: 8133499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multisource ascertainment of Huntington disease in Canada: prevalence and population at risk.
    Fisher ER; Hayden MR
    Mov Disord; 2014 Jan; 29(1):105-14. PubMed ID: 24151181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The epidemiology of Huntington's disease.
    Harper PS
    Hum Genet; 1992 Jun; 89(4):365-76. PubMed ID: 1535611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of adult Huntington's disease in the UK: a UK-based primary care study and a systematic review.
    Wexler NS; Collett L; Wexler AR; Rawlins MD; Tabrizi SJ; Douglas I; Smeeth L; Evans SJ
    BMJ Open; 2016 Feb; 6(2):e009070. PubMed ID: 26908513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uptake of Huntington disease predictive testing in a complete population.
    Morrison PJ; Harding-Lester S; Bradley A
    Clin Genet; 2011 Sep; 80(3):281-6. PubMed ID: 20880124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Huntington's disease: current epidemiology and pharmacological management in UK primary care.
    Sackley C; Hoppitt TJ; Calvert M; Gill P; Eaton B; Yao G; Pall H
    Neuroepidemiology; 2011; 37(3-4):216-21. PubMed ID: 22133668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiological Study of Huntington's Disease in the Province of Ferrara, Italy.
    Carrassi E; Pugliatti M; Govoni V; Sensi M; Casetta I; Granieri E
    Neuroepidemiology; 2017; 49(1-2):18-23. PubMed ID: 28803251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Huntington's disease in Greece: the experience of 14 years.
    Panas M; Karadima G; Vassos E; Kalfakis N; Kladi A; Christodoulou K; Vassilopoulos D
    Clin Genet; 2011 Dec; 80(6):586-90. PubMed ID: 21166788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of Huntington's disease in Slovenia.
    Peterlin B; Kobal J; Teran N; Flisar D; Lovrecić L
    Acta Neurol Scand; 2009 Jun; 119(6):371-5. PubMed ID: 18976322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term monitoring of the mortality trend of Huntington's disease in Austria.
    Ekestern E; Lebhart G
    Eur J Epidemiol; 2005; 20(2):169-72. PubMed ID: 15792284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of Huntington's disease in Finland.
    Sipilä JO; Hietala M; Siitonen A; Päivärinta M; Majamaa K
    Parkinsonism Relat Disord; 2015 Jan; 21(1):46-9. PubMed ID: 25466405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of adult Huntington's disease in the UK based on diagnoses recorded in general practice records.
    Evans SJ; Douglas I; Rawlins MD; Wexler NS; Tabrizi SJ; Smeeth L
    J Neurol Neurosurg Psychiatry; 2013 Oct; 84(10):1156-60. PubMed ID: 23482661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simulation of Huntington's disease onset.
    Markson LE; Chase GA; Brookmeyer R
    Genet Epidemiol; 1989; 6(3):451-9. PubMed ID: 2526776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiological and genetic studies of Huntington's disease in the San-in area of Japan.
    Nakashima K; Watanabe Y; Kusumi M; Nanba E; Maeoka Y; Nakagawa M; Igo M; Irie H; Ishino H; Fujimoto A; Goto J; Takahashi K
    Neuroepidemiology; 1996; 15(3):126-31. PubMed ID: 8700304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The fertility of HD-affected individuals in Tasmania.
    Pridmore SA; Adams GC
    Aust N Z J Psychiatry; 1991 Jun; 25(2):262-4. PubMed ID: 1831608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic mutation in Dutch Huntington's disease patients: increased paternal repeat instability extending to within the normal size range.
    De Rooij KE; De Koning Gans PA; Skraastad MI; Belfroid RD; Vegter-Van Der Vlis M; Roos RA; Bakker E; Van Ommen GJ; Den Dunnen JT; Losekoot M
    J Med Genet; 1993 Dec; 30(12):996-1002. PubMed ID: 8133511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 22 Years of predictive testing for Huntington's disease: the experience of the UK Huntington's Prediction Consortium.
    Baig SS; Strong M; Rosser E; Taverner NV; Glew R; Miedzybrodzka Z; Clarke A; Craufurd D; ; Quarrell OW
    Eur J Hum Genet; 2016 Oct; 24(10):1396-402. PubMed ID: 27165004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic features of Huntington disease in Cuban population: implications for phenotype, epidemiology and predictive testing.
    Vázquez-Mojena Y; Laguna-Salvia L; Laffita-Mesa JM; González-Zaldívar Y; Almaguer-Mederos LE; Rodríguez-Labrada R; Almaguer-Gotay D; Zayas-Feria P; Velázquez-Pérez L
    J Neurol Sci; 2013 Dec; 335(1-2):101-4. PubMed ID: 24054538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.